Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal
Completed
- Conditions
- Hyperlipidemia
- Registration Number
- NCT00781560
- Lead Sponsor
- AstraZeneca
- Brief Summary
This study is designed to survey the awareness rate of Chinese National Adult Lipid Treatment Guideline (2007) by cardiologists; To survey the control rate of the patients with dyslipidemia in "real world"; and to evaluate the percentage of hyperlipidemia patients who achieved target LDL-C level according to the Chinese National Adult Lipid Treatment Guideline (2007) following 8-week treatment by Crestor® 5mg or 10mg
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2575
Inclusion Criteria
- Diagnosed as dyslipidemia by doctors
- Having lipids test and record within one months
- Diagnosed as hypercholesterolemia or mixed dyslipidaemias and has been prescribed Crestor® 5mg or 10mg
Exclusion Criteria
- Unable or unwilling to provide the Inform Consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the awareness rate of Chinese National Adult Lipid Treatment Guideline (2007) by cardiologists 1 time the control rate of patients reaching target LDL-C level 8 weeks
- Secondary Outcome Measures
Name Time Method the percent change from baselines in TC, TG, HDL-C 8 weeks the percentage of hyperlipidemia patients in different risk categories who achieved target LDL-C level according to the Chinese National Adult Lipid Treatment Guideline (2007) 8 weeks
Trial Locations
- Locations (2)
Reseearch Site
🇨🇳Ningbo, Zhejiang, China
Research Site
🇨🇳Hangzhou, Zhejiang, China